Shares of Charles & Colvard, Ltd. (NASDAQ:CTHR) have received a consensus broker rating score of 1.00 (Strong Buy) from the one analysts that provide coverage for the company, Zacks Investment Research reports. One research analyst has rated the stock with a strong buy recommendation.
Brokerages have set a 12 month consensus target price of $2.50 for the company, according to Zacks. Zacks has also given Charles & Colvard, Ltd. an industry rank of 102 out of 256 based on the ratings given to its competitors.
Separately, Roth Capital began coverage on shares of Charles & Colvard, Ltd. in a research report on Wednesday, June 12th. They set a “buy” rating and a $2.50 price objective on the stock.
CTHR stock traded down $0.03 during trading on Tuesday, reaching $1.56. 103,281 shares of the company’s stock were exchanged, compared to its average volume of 144,621. Charles & Colvard, Ltd. has a 1-year low of $0.80 and a 1-year high of $2.48. The company has a fifty day simple moving average of $1.66. The stock has a market capitalization of $44.56 million, a price-to-earnings ratio of 22.21 and a beta of -0.60.
Charles & Colvard, Ltd. (NASDAQ:CTHR) last announced its quarterly earnings results on Thursday, May 9th. The company reported $0.04 earnings per share (EPS) for the quarter. The company had revenue of $7.90 million during the quarter. Charles & Colvard, Ltd. had a net margin of 4.56% and a return on equity of 4.06%. On average, equities research analysts forecast that Charles & Colvard, Ltd. will post 0.1 EPS for the current year.
Charles & Colvard, Ltd. Company Profile
Charles & Colvard, Ltd. manufactures, markets, and distributes moissanite jewels and finished jewelry featuring moissanite worldwide. The company offers near-colorless moissanite jewels cut in various shapes, including round, square brilliant, princess, cushion, radiant, pear, marquise, heart, and oval in sizes ranging from approximately 1.3 to 12 millimeters.
See Also: What is the Dow Jones Industrial Average (DJIA)?
Get a free copy of the Zacks research report on Charles & Colvard, Ltd. (CTHR)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Charles & Colvard Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Charles & Colvard Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.